FibroBiologics (FBLG) PT Lowered to $4 at H.C. Wainwright

February 26, 2026 6:40 AM EST Send to a Friend
H.C. Wainwright analyst Matthew Caufield lowered the price target on FibroBiologics (NASDAQ: FBLG) to $4.00 (from $5.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login